Nanotechnology, Medicine and Bioethics

Nanomedicine and Nanotoxicology Experts to Address President’s Council on Bioethics

WASHINGTON, DC – One of today’s hottest areas of scientific research is nanomedicine. Scientists currently are working to create novel nanostructures that can serve as new kinds of drugs for treating cancer, Parkinson’s, and cardiovascular disease. They also are seeking ways to engineer nanomaterials for use as artificial tissues that could replace diseased kidneys and livers, and even repair nerve damage.

In addition, although the research is still exploratory, scientists are beginning to build nanostructures that mimic complex biomolecules. Some of these engineered structures appear to have regenerative powers that could potentially lead to therapies for conditions such as Alzheimer’s, nerve injury and brain damage from stroke.

Dr. Andrew Maynard, chief science advisor for the Wilson Center’s Project on Emerging Nanotechnologies, and Dr. Mauro Ferrari, chairman, Department of Biomedical Engineering, University of Texas Health Science Center at Houston, were invited to discuss nanotechnology and nanomedicine before a meeting of the President’s Council on Bioethics. At this special session on nanotechnology held on Friday, June 29 they presented the exciting possibilities that these technologies present, as well as potential risks and ethical implications.

Press inquiries: Diane M. Gianelli, Director of Communications, The President’s Council on Bioethics, (202) 296-4669.